These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8870809

  • 21. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium.
    Okuda Y, Kawashima K, Suzuki S, Asakura Y, Asano M, Tsurumaru K, Dai H, Tachi Y, Bannai C, Saitoh M, Yamashita K.
    Life Sci; 1997; 60(3):PL53-6. PubMed ID: 9000650
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of aldose reductase in human erythrocytes by vitamin C.
    Vincent TE, Mendiratta S, May JM.
    Diabetes Res Clin Pract; 1999 Jan; 43(1):1-8. PubMed ID: 10199583
    [Abstract] [Full Text] [Related]

  • 24. Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats.
    Ishii N, Ikenaga H, Ogawa Z, Aoki Y, Saruta T, Suga T.
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):391-8. PubMed ID: 11471882
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA, Borja NL.
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [Abstract] [Full Text] [Related]

  • 29. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    Senthilkumari S, Sharmila R, Chidambaranathan G, Vanniarajan A.
    J Ocul Pharmacol Ther; 2017 May; 33(1):34-41. PubMed ID: 27835059
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - treatment with an aldose reductase inhibitor.
    Tsugawa T, Shinohara R, Nagasaka A, Nakano I, Takeda F, Nagata M, Oda N, Sawai Y, Hayakawa N, Suzuki A, Itoh M.
    J Endocrinol; 2004 Jun; 181(3):429-35. PubMed ID: 15171691
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of fructose supplementation on sorbitol accumulation and myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose concentrations.
    Yorek MA, Dunlap JA, Leeney EM, Stefani MR.
    J Neurochem; 1990 Oct; 55(4):1366-78. PubMed ID: 2118946
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes.
    Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T, Tanaka Y, Kawamori R.
    Endocr J; 2009 Oct; 56(1):149-56. PubMed ID: 18997444
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.